We are developing PointCheck™, the first device for non-invasive white cell monitoring. PointCheck™ is fast, portable and simple to use. By removing the need for a blood draw, millions of immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes.
We are based in Boston (Massachusetts) and Madrid (Spain)
and we are always looking to meet exceptional people interested in working with us
To learn more and to apply, go to: